RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CENDERELLO G
Collezione ASL Città di Torino

Items : 19

People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? in AIDS (London, England) / AIDS. 2024 Mar 1;38(3):430-434. doi: 10.1097/QAD.0000000000003766. Epub 2024 Feb 1.

2024
AOU Alessandria
ASL Città di Torino
AOU Novara

Bonfanti P; De Socio GV; Cascio A; Piccica M; Carleo MA; Cenderello G; Bargiacchi O; Pontali E; Sarchi E; Squillace N; Pellicano' GF; Ferrara S; Menzaghi B; Baldi F; Ricci E; Orofino G; Bartalucci C; Di Biagio A;

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study. in Viruses / Viruses. 2024 Apr 15;16(4):613. doi: 10.3390/v16040613.

2024
AOU Alessandria
ASL Città di Torino
AOU Novara

Bargiacchi O; Ricci ED; Angioni G; Guadagnino G; Martini S; Falasca K; Ferrara S; Carleo MA; Maggi P; Cenderello G; Bandera A; Calza L; Sarchi E; Gulminetti R; Celesia BM; Cascio A; Pontali E; Bellagamba R; Pellicanò GF; Madeddu G; Salomoni E; De Socio GV; Molteni C; Taramasso L; Di Biagio A; Lagi F; Squillace N; Guastavigna M; Orofino G; et alii...

Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study. in Viruses / Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720.

2023
AOU Alessandria
ASL Città di Torino

Di Biagio A; Falasca K; Cenderello G; Cascio A; Sarchi E; Pellicanò GF; Parruti G; Celesia BM; Costa C; Valsecchi L; Molteni C; De Socio GV; Squillace N; Taramasso L; Orofino G; Martinelli CV; Ricci E; Menzaghi B; De Vito A; Bonfanti P; Madeddu G;

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. in Viruses / Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612.

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Bonfanti P; Di Biagio A; Cenderello G; Ferrara S; Falasca K; Bargiacchi O; Martini S; Sarchi E; Calza L; Rusconi S; Valsecchi L; Parisini A; Taramasso L; Carleo MA; Cascio A; Pellicanò GF; Madeddu G; Celesia BM; Vichi F; Bellagamba R; Orofino G; Menzaghi B; Masiello A; Molteni C; Squillace N; De Socio GV; Ricci ED; Martinelli CV; Maggi P; et alii...

Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir. in PloS one / PLoS One. 2023 Aug 9;18(8):e0289132. doi: 10.1371/journal.pone.0289132. eCollection 2023.

2023
AOU Alessandria
ASL Città di Torino
AOU Novara

Di Biagio A; Bargiacchi O; Cascio A; Angioni G; Falasca K; Attala L; Cenderello G; Bandera A; Valsecchi L; Simeone F; Pellicanò GF; Sarchi E; Piconi S; Maurizio Celesia B; Orofino G; De Socio GV; Taramasso L; Menzaghi B; Bonfanti P; Maggi P; Ricci E; Squillace N;

Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort. in Frontiers in medicine / Front Med (Lausanne). 2023 Jan 27;10:1086012. doi: 10.3389/fmed.2023.1086012. eCollection 2023.

2023
ASL Città di Torino

Nicolini LA; Menzaghi B; Ricci E; Pontali E; Cenderello G; Orofino G; Cascio A; Pellicanò GF; Valsecchi L; Molteni C; Vichi F; Bonfanti P; Di Biagio A;

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? in BMC infectious diseases / BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y.

2022
AOU Alessandria
ASL Città di Torino

Falasca K; Calza L; Parisini A; Cenderello G; Gulminetti R; Valsecchi L; Celesia BM; Martinelli CV; Pellicanò G; Sarchi E; Vichi F; Cascio A; Madeddu G; Gamboni G; Guastavigna M; Taramasso L; Molteni C; Squillace N; Menzaghi B; De Socio GV; Maggi P; Orofino G; Ricci E; Di Biagio A; Bonfanti P;

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. in AIDS patient care and STDs / AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089.

2021
AOU Alessandria
ASL Città di Torino

Dentone C; Bandera A; Cenderello G; Guadagnino G; Angioni G; Vichi F; Maggi P; Cascio A; Martinelli CV; Valsecchi L; Rusconi S; Calza L; Celesia BM; Sarchi E; Pellicanò GF; De Socio GV; Gulminetti R; Molteni C; Menzaghi B; Squillace N; Ricci ED; Orofino G; Taramasso L; De Vito A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;

Factors associated with hospital admission for COVID-19 in HIV patients. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1983-1985. doi: 10.1097/QAD.0000000000002663.

2020
ASL Città di Torino
AOU Novara

Falasca K; Maggi P; Saracino A; Ferrara S; Cenderello G; Valsecchi L; Molteni C; Bargiacchi O; Orofino G; Rusconi S; Menzaghi B; Squillace N; Calza L; Ricci E; Di Biagio A; Taramasso L; Bonfanti P;

Factors Associated With Weight Gain in People Treated With Dolutegravir. in Open forum infectious diseases / Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun.

2020
AOU Alessandria
ASL Città di Torino

Dentone C; Vichi F; Maggi P; Bolla C; Cascio A; Valsecchi L; Martinelli CV; Conti F; Calza L; Celesia BM; Pagnucco L; Pellicanò GF; Madeddu G; De Socio GV; Menzaghi B; Squillace N; Orofino G; Ricci E; Bonfanti P; Taramasso L; Angioni G; Mastroianni A; Falasca K; Cenderello G; Di Biagio A;

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? in AIDS (London, England) / AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784.

2018
ASL Città di Torino

Capetti AF; Orofino G; Paladini L; Sterrantino G; DiGiambenedetto S; De Socio GV; Cenderello G; Cossu MV; Rizzardini G;

CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? in The Journal of allergy and clinical immunology / J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov

2018
ASL Città di Torino

Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc. in International journal of STD & AIDS / Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

2017
ASL Città di Torino

Dentone C; Sterrantino G; Signori A; Cenderello G; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Giacomini M; Bruzzone B; Francisci D; Di Biagio A;

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.

2017
ASL Città di Torino

Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. in Current HIV research / Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135.

2016
ASL Città di Torino

Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S;

'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation. in Nature communications / Nat Commun. 2015 Oct 5;6:8109. doi: 10.1038/ncomms9109.

2015
ASL Città di Torino

Bozzano F; Marras F; Ascierto ML; Cantoni C; Cenderello G; Dentone C; Di Biagio A; Orofino G; Mantia E; Boni S; De Leo P; Picciotto A; Braido F; Antonini F; Wang E; Marincola F; Moretta L; De Maria A;

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. in AIDS (London, England) / AIDS. 2014 Apr 24;28(7):1071-4. doi: 10.1097/QAD.0000000000000194.

2014
ASL Città di Torino

Dentone C; Di Biagio A; Parodi A; Bozzano F; Fraccaro P; Signori A; Cenderello G; Mantia E; Orofino G; De Maria A; Filaci G; Fenoglio D;

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

2014
ASL Città di Torino

Dentone C; Fenoglio D; Signori A; Cenderello G; Parodi A; Bozzano F; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Kalli F; Marras F; Fraccaro P; Giacomini M; Cassola G; Bruzzone B; Ferrea G; Viscoli C; Filaci G; De Maria A; Di Biagio A;